Table 2.
Patient Characteristics in the Preintervention and Intervention Phases
| Patient Characteristics | Before Intervention (August 2019-August 2020) | Intervention (August 2020-May 2021) | P Value |
|---|---|---|---|
| No. of patients | 1,090 | 1,026 | … |
| Average no. of visits per patient | 3.1 | 2.3 | … |
| Screening benefit level | .619 | ||
| High | 731 (67.1) | 676 (65.9) | … |
| Intermediate | 359 (32.9) | 350 (34.1) | … |
| Pulmonologist involvement | .079 | ||
| No pulmonary visits | 1,000 (91.7) | 962 (93.8) | |
| At least 1 pulmonary visit | 90 (8.3) | 64 (6.2) | |
| Female sex | 458 (42.0) | 441 (43.0) | .751 |
| Race and ethnicity | .827 | ||
| Non-Hispanic White | 944 (86.6) | 902 (87.9) | |
| Non-Hispanic Black | 17 (1.6) | 17 (1.7) | |
| Hispanic | 68 (6.2) | 57 (5.6) | |
| Other | 61 (5.6) | 50 (4.9) | |
| Age, y | 65.2 (6.6) | 65.3 (6.6) | .991 |
| Tobacco use | |||
| No. of cigarettes/d | 25.0 ± 10.6 | 24.6 ± 10.1 | .022a |
| No. of years smoked | 38.9 ± 9.5 | 39.2 ± 9.1 | .43 |
| Current or former tobacco use | .422 | ||
| Current tobacco use | 574 (52.7) | 555 (54.1) | |
| Former tobacco use, quit < 15 y ago | 516 (47.3) | 471 (45.9%) | |
| Years since last quit for former tobacco use | 7.3 ± 4.3 | 7.6 ± 4.3 | .219 |
| Comorbidities and conditions | |||
| Angina pectoris | 95 (8.7) | 87 (8.5) | .775 |
| Cancer | 265 (24.3) | 254 (24.8) | .845 |
| Chronic bronchitis | 158 (14.5) | 140 (13.6) | .492 |
| Chronic kidney disease | 217 (19.9) | 210 (20.5) | .819 |
| COPD or emphysema | 495 (45.4) | 475 (46.3) | .746 |
| Coronary artery disease | 274 (25.1) | 271 (26.4) | .575 |
| Diabetes | 315 (28.9) | 303 (29.5) | .868 |
| Dependence on medical equipment | 5 (0.5) | 8 (0.8) | .37 |
| Heart attack | 135 (12.4) | 128 (12.5) | .989 |
| Hypertension | 718 (65.9) | 686 (66.9) | .783 |
| Liver disease | 190 (17.4) | 174 (17.0) | .76 |
| Other heart diseases | 306 (28.1) | 299 (29.1) | .698 |
| Stroke | 114 (10.5) | 113 (11.0) | .791 |
| CCI | 3.1 ± 2.8 | 3.2 ± 2.8 | .815 |
| Other factors | |||
| BMI, kg/m2 | 29.0 ± 6.9 | 29.0 ± 7.0 | .88 |
| Parent(s) with lung cancer history | 67 (6.1) | 65 (6.3) | .828 |
| Patient portal used in the preceding year | 637 (58.4) | 691 (67.3) | < .001a |
| COVID-19 hospitalizations in Utah | 7.8 ± 8.5 | 43.9 ± 19.5 | < .001a |
| Insurance | .176 | ||
| Commercial | 330 (30.3) | 301 (29.3) | |
| Government | 711 (65.2) | 694 (67.6) | |
| Self-pay | 49 (4.5) | 31 (3.0) | |
| Needed LCS SDM | 1,085 (99.5) | 1,010 (98.4) | .02a |
Data are presented as No. (%) or mean ± SD, unless otherwise indicated. CCI = Charlson Comorbidity Index; LCS = lung cancer screening; SDM = shared decision-making.
a
P < .05.